Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.35 $5.09 Wednesday, 8th May 2024 RLMD stock ended at $3.83. This is 0.262% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.32% from a day low at $3.75 to a day high of $3.95.
90 days $3.35 $7.22
52 weeks $2.36 $7.22

Historical Relmada Therapeutics, Inc. prices

Date Open High Low Close Volume
Feb 27, 2024 $6.00 $6.04 $5.80 $5.93 162 701
Feb 26, 2024 $5.70 $6.08 $5.62 $5.91 153 915
Feb 23, 2024 $5.54 $5.82 $5.48 $5.68 124 917
Feb 22, 2024 $5.75 $5.80 $5.38 $5.54 128 883
Feb 21, 2024 $5.83 $5.96 $5.41 $5.69 223 262
Feb 20, 2024 $5.60 $6.25 $5.59 $5.96 468 173
Feb 16, 2024 $5.29 $5.65 $5.20 $5.59 175 105
Feb 15, 2024 $5.45 $5.50 $5.01 $5.27 246 983
Feb 14, 2024 $5.27 $5.92 $5.27 $5.50 353 194
Feb 13, 2024 $5.39 $5.41 $5.12 $5.16 204 033
Feb 12, 2024 $5.50 $5.65 $5.38 $5.52 205 422
Feb 09, 2024 $5.29 $5.52 $5.21 $5.45 206 367
Feb 08, 2024 $5.17 $5.30 $5.05 $5.24 205 922
Feb 07, 2024 $5.46 $5.46 $4.99 $5.13 346 081
Feb 06, 2024 $5.25 $5.69 $5.11 $5.40 613 489
Feb 05, 2024 $4.66 $5.17 $4.26 $5.04 720 181
Feb 02, 2024 $4.55 $4.84 $4.44 $4.60 250 898
Feb 01, 2024 $4.36 $4.72 $4.09 $4.56 697 131
Jan 31, 2024 $3.91 $4.19 $3.89 $3.93 168 899
Jan 30, 2024 $3.71 $3.99 $3.64 $3.98 268 696
Jan 29, 2024 $3.63 $3.78 $3.55 $3.72 191 730
Jan 26, 2024 $3.65 $3.67 $3.52 $3.63 71 065
Jan 25, 2024 $3.53 $3.64 $3.51 $3.62 75 740
Jan 24, 2024 $3.44 $3.55 $3.32 $3.51 138 496
Jan 23, 2024 $3.61 $3.66 $3.38 $3.42 81 037
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT